# Performance and Safety of HyalganBio® Intra-Articular Injections as Add-On to Physical Exercise for Symptomatic Glenohumeral Osteoarthritis

> **NCT07520708** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Fidia Farmaceutici s.p.a.** · enrollment: 72 (actual)

## Conditions studied

- Glenohumeral Osteoarthritis

## Interventions

- **DEVICE:** Hyaluronic acid plus Physical Exercise Program (PEP)

## Key facts

- **NCT ID:** NCT07520708
- **Lead sponsor:** Fidia Farmaceutici s.p.a.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-07-12
- **Primary completion:** 2026-10
- **Final completion:** 2026-10
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2026-04-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07520708

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07520708, "Performance and Safety of HyalganBio® Intra-Articular Injections as Add-On to Physical Exercise for Symptomatic Glenohumeral Osteoarthritis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07520708. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*